X0306 4 2021-12-01 0 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001075050 KAZIMI A J 2525 WEST END AVE. SUITE 950 NASHVILLE TN 37203 1 1 1 0 Chairman and CEO Common Stock 2021-12-01 4 P 0 18 4.14 A 5770187 D Common Stock 2021-12-02 4 P 0 18 3.84 A 5770205 D Common Stock 2021-12-03 4 P 0 18 4.47 A 5770223 D Common Stock 2021-12-06 4 P 0 18 4.46 A 5770241 D Common Stock 2021-12-07 4 P 0 18 5.61 A 5770259 D Common Stock 2021-12-08 4 P 0 18 6.15 A 5770277 D Common Stock 2021-12-09 4 P 0 18 5.81 A 5770295 D Common Stock 2021-12-10 4 P 0 18 4.82 A 5770313 D Common Stock 2021-12-13 4 P 0 30 4.36 A 5770343 D Common Stock 2021-12-14 4 P 0 30 4.28 A 5770373 D Common Stock 2021-12-15 4 P 0 30 4.29 A 5770403 D Common Stock 2021-12-16 4 P 0 50 4.53 A 5770453 D Common Stock 2021-12-17 4 P 0 50 4.17 A 5770503 D Common Stock 2021-12-20 4 P 0 60 4.33 A 5770563 D The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. A.J. Kazimi by /s/ John Hamm as attorney-in-fact 2022-01-07